{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:49:27Z","timestamp":1792788567490,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"41","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Oromia Regional Health Bureau","id":[{"id":"https:\/\/ror.org\/01d1vqp66","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.vaccine.2020.08.018","type":"journal-article","created":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T09:37:30Z","timestamp":1597052250000},"page":"6374-6380","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["The effect of Bacillus Calmette\u2013Gu\u00e9rin (BCG) vaccination in preventing severe infectious respiratory diseases other than TB: Implications for the COVID-19 pandemic"],"prefix":"10.1016","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4935-6871","authenticated-orcid":false,"given":"Kiddus","family":"Yitbarek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gelila","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsinuel","family":"Girma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tizta","family":"Tilahun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirkuzie","family":"Woldie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.vaccine.2020.08.018_b0005","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.vaccine.2009.01.034","article-title":"Whole genome sequence analysis of Mycobacterium bovis bacillus Calmette-Gu\u00e9rin (BCG) Tokyo 172: a comparative study of BCG vaccine substrains","volume":"27","author":"Seki","year":"2009","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2020.08.018_b0010","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.vaccine.2017.12.010","article-title":"Bacillus Calmette-Gu\u00e9rin (BCG) vaccine: a global assessment of demand and supply balance","volume":"36","author":"Cernuschi","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.08.018_b0015","doi-asserted-by":"crossref","DOI":"10.3310\/hta17370","article-title":"Systematic review and meta-analysis of the current evidence on the duration of protection by bacillus Calmette-Gu\u00e9rin vaccination against tuberculosis","author":"Abubakar","year":"2013","journal-title":"Health Technol Assess"},{"issue":"6","key":"10.1016\/j.vaccine.2020.08.018_b0020","first-page":"635","article-title":"Timing and dose of BCG vaccination in infants as assessed by postvaccination tuberculin sensitivity","volume":"32","author":"Aggarwal","year":"1995","journal-title":"Indian Pediatr"},{"issue":"9517","key":"10.1016\/j.vaccine.2020.08.018_b0025","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(06)68507-3","article-title":"Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness","volume":"367","author":"Trunz","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2020.08.018_b0030","unstructured":"NHS and Centre for Clinical Practice at NICE. Respiratory tract infections \u2013 antibiotic prescribing; 2018."},{"key":"10.1016\/j.vaccine.2020.08.018_b0035","unstructured":"Oxford University press. \u201cOxford Medicine Online: Infectious diseases\u201d; 2020. [Online]. Available: https:\/\/oxfordmedicine.com\/."},{"key":"10.1016\/j.vaccine.2020.08.018_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.pcl.2009.09.003","article-title":"Lower respiratory tract infections","author":"Chang","year":"2009","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.vaccine.2020.08.018_b0045","doi-asserted-by":"crossref","unstructured":"Heikkinen T, Ruuskanen O. Upper respiratory tract infection. In: Encyclopedia of respiratory medicine, four-volume set; 2006. p. 385\u20138.","DOI":"10.1016\/B0-12-370879-6\/00416-6"},{"issue":"43","key":"10.1016\/j.vaccine.2020.08.018_b0050","doi-asserted-by":"crossref","first-page":"6510","DOI":"10.1016\/j.vaccine.2019.08.067","article-title":"BCG vaccine and leprosy household contacts: protective effect and probability to becoming sick during follow-up","volume":"37","author":"Gomes","year":"2019","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2020.08.018_b0055","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.cmi.2019.04.020","article-title":"Non-specific effects of BCG vaccine on viral infections","volume":"25","author":"Moorlag","year":"2019","journal-title":"Clin Microbiol Infect"},{"issue":"9","key":"10.1016\/j.vaccine.2020.08.018_b0060","doi-asserted-by":"crossref","first-page":"5403","DOI":"10.1128\/IAI.69.9.5403-5411.2001","article-title":"Protective efficacy of a DNA vaccine encoding antigen 85A from Mycobacterium bovis BCG against Buruli ulcer","volume":"69","author":"Tanghe","year":"2001","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2020.08.018_b0065","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1093\/aje\/kwx088","article-title":"Association between bacillus Calmette-Gu\u00e9rin vaccination and childhood asthma in the Quebec birth cohort on immunity and health","volume":"186","author":"El-Zein","year":"2017","journal-title":"Am J Epidemiol"},{"issue":"2","key":"10.1016\/j.vaccine.2020.08.018_b0070","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/all.13314","article-title":"Neonatal BCG vaccination and atopic dermatitis before 13 months of age: a randomized clinical trial","volume":"73","author":"Th\u00f8stesen","year":"2018","journal-title":"Allergy Eur J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2020.08.018_b0075","first-page":"93","article-title":"Human immunodeficiency virus and hepatitis C virus co-infection: epidemiology, natural history and the situation in China","volume":"122","author":"Gen-sheng","year":"2009","journal-title":"Chin Med J (Engl)"},{"issue":"1","key":"10.1016\/j.vaccine.2020.08.018_b0080","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1542\/peds.2013-2218","article-title":"Acute lower respiratory infection among Bacille Calmette-Gu\u00e9rin (BCG)\u2013vaccinated children","volume":"133","author":"Hollm-Delgado","year":"2014","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.vaccine.2020.08.018_b0085","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.clinthera.2013.01.007","article-title":"Nonspecific effects of vaccines and the reduction of mortality in children","volume":"35","author":"Shann","year":"2013","journal-title":"Clin Ther"},{"key":"10.1016\/j.vaccine.2020.08.018_b0090","unstructured":"The Mendeley Support Team. \u201cGetting Started with Mendeley.\u201d London: Mendeley Desktop. Mendeley Ltd.; 2011. p. 1\u201316."},{"key":"10.1016\/j.vaccine.2020.08.018_b0095","unstructured":"Checklist for Cohort Studies: The Joanna Briggs Institute Critical Appraisal tools for use in JBI Systematic Reviews; 2017."},{"key":"10.1016\/j.vaccine.2020.08.018_b0100","unstructured":"Checklist for Case Control Studies: The Joanna Briggs Institute Critical Appraisal tools for use in JBI Systematic Reviews; 2017."},{"key":"10.1016\/j.vaccine.2020.08.018_b0105","unstructured":"Checklist for Randomized Controlled Trials: The Joanna Briggs Institute Critical Appraisal tools for use in JBI Systematic Reviews; 2017."},{"key":"10.1016\/j.vaccine.2020.08.018_b0110","unstructured":"Checklist for Prevalence Studies: The Joanna Briggs Institute Critical Appraisal tools for use in JBI Systematic Reviews; 2017."},{"key":"10.1016\/j.vaccine.2020.08.018_b0115","unstructured":"Pearson A, Field J, Field J. Critical appraisal tools JBI critical appraisal checklist for experimental studies."},{"key":"10.1016\/j.vaccine.2020.08.018_b0120","unstructured":"J.B. Institute. JBI Reviewer Mannual: Data extercation; 2019."},{"issue":"SUPPL. 1","key":"10.1016\/j.vaccine.2020.08.018_b0125","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0195-6701(81)80005-9","article-title":"Respiratory tract infections","volume":"2","author":"Meers","year":"1981","journal-title":"J Hosp Infect"},{"issue":"12","key":"10.1016\/j.vaccine.2020.08.018_b0130","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1542\/pir.35.12.519","article-title":"Respiratory syncytial virus infection and bronchiolitis","volume":"35","author":"Piedimonte","year":"2014","journal-title":"Pediatr Rev"},{"key":"10.1016\/j.vaccine.2020.08.018_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102433","article-title":"The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak","author":"Rothan","year":"2020","journal-title":"J Autoimmun"},{"key":"10.1016\/j.vaccine.2020.08.018_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpha.2020.03.001","article-title":"Molecular immune pathogenesis and diagnosis of COVID-19","author":"Li","year":"2020","journal-title":"J Pharm Anal"},{"issue":"3","key":"10.1016\/j.vaccine.2020.08.018_b0145","first-page":"185","article-title":"The efficacy of Bacillus Calmette-Guerin vaccinations for the prevention of acute upper respiratory tract infection in the elderly","volume":"43","author":"Wardhana","year":"2011","journal-title":"Acta Med Indones"},{"issue":"9","key":"10.1016\/j.vaccine.2020.08.018_b0150","first-page":"1689","article-title":"Correlation between universal BCG vaccination policy and reduced morbidity and mortality for COVID-19: an epidemiological study","volume":"53","author":"Miller","year":"2020","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.vaccine.2020.08.018_b0155","first-page":"1","article-title":"BCG vaccine protection from severe coronavirus","author":"Escobar","year":"2020","journal-title":"PNAS Appl Biol Sci"},{"issue":"12","key":"10.1016\/j.vaccine.2020.08.018_b0160","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1093\/infdis\/jiv332","article-title":"BCG vaccination enhances the immunogenicity of subsequent influenza vaccination in healthy volunteers: a randomized, placebo-controlled pilot study","volume":"212","author":"Leentjens","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.08.018_b0165","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.vaccine.2004.09.006","article-title":"Acute lower respiratory tract infections and respiratory syncytial virus in infants in Guinea-Bissau: a beneficial effect of BCG vaccination for girls Community based case \u2013 control study","volume":"23","author":"Stensballe","year":"2005","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2020.08.018_b0170","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1093\/cid\/civ144","article-title":"Nonspecific (heterologous) protection of neonatal BCG vaccination against hospitalization due to respiratory infection and sepsis","volume":"60","author":"De Castro","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2020.08.018_b0175","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/ije\/dyh392","article-title":"BCG vaccination scar associated with better childhood survival in Guinea-Bissau","volume":"34","author":"Roth","year":"2005","journal-title":"Int J Epidemiol"},{"issue":"43","key":"10.1016\/j.vaccine.2020.08.018_b0180","doi-asserted-by":"crossref","first-page":"17537","DOI":"10.1073\/pnas.1202870109","article-title":"Bacille Calmette-Gu\u00e9rin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes","volume":"109","author":"Kleinnijenhuis","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"10.1016\/j.vaccine.2020.08.018_b0185","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.vaccine.2016.12.048","article-title":"A single, low dose of a cGMP recombinant BCG vaccine elicits protective T cell immunity against the human respiratory syncytial virus infection and prevents lung pathology in mice","volume":"35","author":"C\u00e9spedes","year":"2017","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2020.08.018_b0190","first-page":"53","article-title":"History of BCG Vaccine","volume":"8","author":"Luca","year":"2013","journal-title":"Maedica (Buchar)"},{"issue":"9","key":"10.1016\/j.vaccine.2020.08.018_b0195","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1080\/21645515.2017.1334026","article-title":"A safe and ef fi cient BCG vectored vaccine to prevent the disease caused by the human Respiratory Syncytial Virus","volume":"13","author":"Rey-jurado","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2020.08.018_b0200","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/trstmh\/tru161","article-title":"The heterologous (non-specific) effects of vaccines: implications for policy in high-mortality countries","volume":"109","author":"Shann","year":"2015","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.vaccine.2020.08.018_b0205","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s10096-017-3097-2","article-title":"Bacillus Calmette-Gu\u00e9rin vaccination at birth and in vitro cytokine responses to non-specific stimulation. A randomized clinical trial","volume":"37","author":"Nissen","year":"2018","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2020.08.018_b0210","unstructured":"worldometers.info. Coronavirus Update (Live): Worldometer; 2020. [Online]. Available: https:\/\/www.worldometers.info\/coronavirus\/ [accessed: 04-Jun-2020]."},{"key":"10.1016\/j.vaccine.2020.08.018_b0215","doi-asserted-by":"crossref","DOI":"10.1038\/nature08260","article-title":"In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses","author":"Itoh","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2020.08.018_b0220","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa0904023","article-title":"Severe respiratory disease concurrent with the circulation of H1N1 influenza","author":"Chowell","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2020.08.018_b0225","doi-asserted-by":"crossref","unstructured":"Grief SN. Upper Respiratory Infections. Elsevier Inc; 2013. p. 757\u201370.","DOI":"10.1016\/j.pop.2013.06.004"},{"issue":"2","key":"10.1016\/j.vaccine.2020.08.018_b0230","first-page":"260","article-title":"The management of upper respiratory tract infections","volume":"56","author":"Teng","year":"2001","journal-title":"Contin Med Educ"},{"issue":"210","key":"10.1016\/j.vaccine.2020.08.018_b0235","first-page":"1","article-title":"The burden of respiratory infections among older adults in long-term care: a systematic review","volume":"19","author":"Childs","year":"2019","journal-title":"BMC Geriatr"},{"issue":"3","key":"10.1016\/j.vaccine.2020.08.018_b0240","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1172\/JCI64096","article-title":"Review series Causes, consequences, and reversal of immune system aging","volume":"123","author":"Montecino-rodriguez","year":"2013","journal-title":"J Clin Invest"},{"issue":"Suppl. 5","key":"10.1016\/j.vaccine.2020.08.018_b0245","first-page":"S422","article-title":"Aging of the immune system mechanisms and therapeutic targets","volume":"13","author":"Weyand","year":"2016","journal-title":"Transatl Airw Conf"},{"issue":"10","key":"10.1016\/j.vaccine.2020.08.018_b0250","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.2217\/fmb-2018-0026","article-title":"Heterologous effects of infant BCG vaccination: potential mechanisms of immunity","volume":"13","author":"Butkeviciute","year":"2018","journal-title":"Future Microbiol"},{"key":"10.1016\/j.vaccine.2020.08.018_b0255","doi-asserted-by":"crossref","DOI":"10.1038\/pr.2016.142","article-title":"Nonspecific effect of BCG vaccination at birth on early childhood infections: a randomized, clinical multicenter trial","author":"Kj\u00e6rgaard","year":"2016","journal-title":"Pediatr Res"},{"issue":"7","key":"10.1016\/j.vaccine.2020.08.018_b0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0180143","article-title":"Boosting efferocytosis in alveolar space using BCG vaccine to protect host against influenza pneumonia","volume":"12","author":"Mukherjee","year":"2017","journal-title":"PLoS ONE"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20310495?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20310495?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:46:38Z","timestamp":1759401998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20310495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":52,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S0264410X20310495"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.08.018","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of Bacillus Calmette\u2013Gu\u00e9rin (BCG) vaccination in preventing severe infectious respiratory diseases other than TB: Implications for the COVID-19 pandemic","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.08.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}